Company enters 2026 focused on disciplined expansion, national partnerships, and scalable solutions to the growing ...

In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

DriveItAway Holdings, Inc. (OTC: DWAY) ("DriveItAway" or the "Company"), a digital mobility platform enabling flexible vehicle access and subscription-to-ownership ...

Contingency management theory says there’s no one-size-fits-all approach — leaders must adapt strategies based on people, ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

To continuously observe how China is perceived by the world, the Global Times once again launched the "Global Survey on ...

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...

As the world enters 2026, global supply chains are fracturing once again, not from sudden shock but from sustained structural ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...

The Maternal Care Bundle (MCB) sets best practice standards across 5 areas of clinical care, for implementation by NHS providers and commissioners across England. The aim is to reduce maternal ...